Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers

NCT06194357 | Completed

• 1 other identifier: KW/EX-23-001(179-01)
• Study Type: interventional
• Target: 600
• Locations: 1 country
• Sites: 2

Brief Summary

This study examines the effectiveness of a 16-week Integrated Mindfulness-based Health Qigong (iMBHQ) program, delivered via a mobile application, in improving the mental and physical well-being of COVID-19 survivors, their caregivers, and the general public. We hypothesize that participants in the iMBHQ group will demonstrate significant reductions in stress, depression, and anxiety compared to a control group receiving treatment-as-usual. This parallel-group randomized controlled trial aims to recruit 600 participants (200 COVID-19 survivors, 200 caregivers, and 200 individuals from the general public). Effectiveness is evaluated at baseline, 8 weeks, 16 weeks, 6 months, and 12 months post-intervention, using standardized psychological and physical health assessments.

Conditions

COVID-19 Infection

Keywords

COVID-19 Survivors; caregivers; mindfulness-based health Qigong intervention; physical wellness; psychological wellness

Outcome Measures

Primary Outcomes (1)

• Psychological Symptoms

  Depression, Anxiety and Stress Scale (DASS-12)

  From baseline to 12 months post-intervention

Secondary Outcomes (1)

• Interoception, Quality of Life, Rumination, Hyperarousal, Fear and Stigma Towards COVID-19, Attitude toward rapid testing and vaccine

  From baseline to 12 months post-intervention

Study Arms (2)

Intervention group

EXPERIMENTAL

Intervention group will receive training on Qigong exercise and mindfulness.

Other: Mindfulness-based Health Qigong Intervention

Control group

NO INTERVENTION

Control group will not receive intervention.

Interventions

Mindfulness-based Health Qigong Intervention OTHER

Participants are introduced the practice of the most essential skills, particularly mindfulness and the basic movements of Qigong. The intervention lasts 16 weeks and is divided into two sequential 8-week phases: Phase 1 (Weeks 1-8): Participants complete mindfulness-based sessions lasting 2 to 2.5 hours per week. They are also instructed to complete three self-practice sessions (5 to 10 minutes per session), scheduled flexibly at their convenience. Phase 2 (Weeks 9-16): Participants complete 40 sessions of Health Qigong (5 sessions per week, 30 minutes each). To verify compliance, participants must upload a 1-minute self-practice video to the mobile application each week.

Intervention group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• COVID-19 survivors: people aged 18 years or above who were infected by COVID-19 (both symptomatic and asymptomatic) and clinically recovered
• Caregivers of COVID-19 patients, including family members or medical professionals who have contacts with patients diagnosed COVID-19 aged 18 years or above
• General healthy public aged 18 years or above

You may not qualify if:

• people diagnosed severe and/or chronic conditions that prevent the practice of Qigong (e.g., acute exacerbation of dyspnoea, severe cardiopulmonary disease) or mindfulness intervention,
• people with severe psychiatric disorder
• people who have regular psychiatric follow-ups

Sponsors & Collaborators

• TSANG Hector Wing-Hong: lead
• Health and Medical Research Fund: collaborator

Study Sites (2)

Princess Margaret Hospital

Hong Kong, Hong Kong

Location

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

COVID-19; Psychological Well-Being

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Personal Satisfaction; Behavior

Study Officials

• Wing Hong, Hector TSANG, Prof

  Department of Rehabilitation Science, Faculty of Health and Social Sciences

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: January 4, 2024
• First Posted: January 8, 2024
• Study Start: November 8, 2022
• Primary Completion: March 28, 2026
• Study Completion: March 31, 2026
• Last Updated: July 6, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will not share

Locations

HK (2)